Payers and providers face challenges surrounding data integration, patient engagement, and financial pressures when trying to ...

Etonogestrel-releasing contraceptive implants in women with sickle cell disease significantly reduced pain intensity and ...

ILAs in patients with COPD are associated with lower lung cancer incidence but higher prevalence of other cancers and heart ...

Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.

A new study identifies potential immune profile differences in patients with chronic lymphocytic leukemia (CLL) that may lead ...

A new subgroup analysis of patients with muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) myasthenia gravis ...

Groundbreaking proposal to expand contraception coverage under the ACA marks the most significant update in over 10 years.

Medicaid, Medicare, and private insurance programs all showed significant variability in expenditures based on social and ...

Childhood adversities have distinct effects on mental health and cognitive development, necessitating a nuanced understanding ...

The comparative effectiveness study found that the addition of selexipag (Uptravi) to double oral therapy (DOT) reduced the ...

A pioneering program targeting gut microbiome health significantly reduces cancer treatment side effects, enhancing patient well-being and resilience.

Kimberly Westrich, MA, of National Pharmaceutical Council, and Adam Colborn, JD, of AMCP, run through the current status of lawsuits and lawmaking at the federal and state levels related to pharmacy ...